Literature DB >> 10320862

Does cryptogenic fibrosing alveolitis carry an increased risk of death from lung cancer?

J M Harris1, P Cullinan, J C McDonald.   

Abstract

Entities:  

Mesh:

Year:  1998        PMID: 10320862      PMCID: PMC1756764          DOI: 10.1136/jech.52.9.602

Source DB:  PubMed          Journal:  J Epidemiol Community Health        ISSN: 0143-005X            Impact factor:   3.710


× No keyword cloud information.
  2 in total

1.  Rising mortality from cryptogenic fibrosing alveolitis.

Authors:  I Johnston; J Britton; W Kinnear; R Logan
Journal:  BMJ       Date:  1990-11-03

2.  Cryptogenic fibrosing alveolitis and lung cancer.

Authors:  M Turner-Warwick; M Lebowitz; B Burrows; A Johnson
Journal:  Thorax       Date:  1980-07       Impact factor: 9.139

  2 in total
  5 in total

1.  Primary pulmonary collision tumor with three components in the underlying interstitial lung disease.

Authors:  Shigeki Suzuki; Takashi Ohtsuka; Tai Hato; Ikuo Kamiyama; Taichiro Goto; Mitsutomo Kohno; Katsura Emoto; Yuichiro Hayashi
Journal:  Thorac Cancer       Date:  2014-08-25       Impact factor: 3.500

2.  Altered intercellular communication in lung fibroblast cultures from patients with idiopathic pulmonary fibrosis.

Authors:  Angela Trovato-Salinaro; Elisa Trovato-Salinaro; Marco Failla; Claudio Mastruzzo; Valerio Tomaselli; Elisa Gili; Nunzio Crimi; Daniele Filippo Condorelli; Carlo Vancheri
Journal:  Respir Res       Date:  2006-09-27

3.  Interstitial Lung Disease and Lung Cancer Development: A 5-Year Nationwide Population-Based Study.

Authors:  Won-Il Choi; Sun Hyo Park; Byeong Ju Park; Choong Won Lee
Journal:  Cancer Res Treat       Date:  2017-05-08       Impact factor: 4.679

4.  Lung cancer in idiopathic pulmonary fibrosis: A systematic review and meta-analysis.

Authors:  AliReza JafariNezhad; Mohammad Hossein YektaKooshali
Journal:  PLoS One       Date:  2018-08-16       Impact factor: 3.240

Review 5.  The epidemiology of interstitial lung disease and its association with lung cancer.

Authors:  G Raghu; F Nyberg; G Morgan
Journal:  Br J Cancer       Date:  2004-08       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.